The Valley Desk

NCT05485961 · Interventional trial

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Overall registry status Recruiting

Phase 2 · Phase 3

Conditions End Stage Kidney Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov